Latest headcount
137
YoY change
-11.6%
Headcount CAGR
+102.7%
Revenue / employee
$455K
Employee count history for Tango Therapeutics
| Fiscal year | Employees |
|---|---|
| 2020 | 4 |
| 2021 | 91 |
| 2022 | 110 |
| 2023 | 140 |
| 2024 | 155 |
| 2025 | 137 |
Revenue per employee for Tango Therapeutics
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 2020 | $1.91M |
| 2021 | $407K |
| 2022 | $226K |
| 2023 | $261K |
| 2024 | $271K |
| 2025 | $455K |
Earnings per employee for Tango Therapeutics
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 2020 | -$13M |
| 2021 | -$640K |
| 2022 | -$983K |
| 2023 | -$727K |
| 2024 | -$841K |
| 2025 | -$742K |
Employee count history for Tango Therapeutics (TNGX)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 2025137-11.6%
- 2024155+10.7%
- 2023140+27.3%
- 2022110+20.9%
- 202191+2,175.0%
- 20204—
About Tango Therapeutics's employee count
Tango Therapeutics (TNGX) employed 137 people in fiscal year 2025, based on its most recent annual report. That headcount shrank by -18 (-11.6%) from 155 a year earlier.
Across the 2020–2025 period, the company's reported workforce went from 4 to 137 employees — a compound annual growth rate (CAGR) of +102.7% per year.
Tango Therapeutics generated about $455K of revenue and -$742K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on TNGX
Employees — 10 rounds, every one of them TNGX against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.